Stocks in Focus

Subsidiary Supplies to Naver Cloud… M83 Hits Consecutive Daily Price Limits [Featured Stock]

Kwon Oh Seok
2026-06-04 09:11:12
[Edaily Reporter Kwon Oh-seok] The stock price of #M83, a company specializing in visual effects (VFX), has hit the daily price limit for two consecutive trading days. It appears that buying interest is surging following news that its subsidiary, P&T Link, has begun supplying artificial intelligence (AI) infrastructure to Naver Cloud.

According to MP Doctor on the 4th, as of 9:09 a.m., M83 is trading at the daily price limit of 7,760 won, up 29.98% from the previous trading day.
Previously, on the 2nd, M83 issued a press release announcing that its subsidiary, P&T Link, had signed a contract worth approximately 50 billion won annually to supply standard servers for AI infrastructure to Naver Cloud. The supply period is scheduled to continue until March of next year. As a result, the stock price closed at the daily limit up on the same day.
P&T Link is engaged in businesses such as graphics processing unit (GPU) servers, AI storage, industrial servers, and AI infrastructure construction. In response to the growing demand for high-performance servers driven by the recent proliferation of generative AI, the company is aggressively expanding its related businesses.
P&T Link is expanding its business scope beyond simple server supply to include AI infrastructure construction and maintenance. Based on existing supply projects, the company plans to actively respond to future demand for additional expansion and maintenance.

Economy

Corporation

IT·Science

Economy

[VC's Pick] LegalTech Firm 'Legora' Expands into Korea, Secures Series E Funding

This week (October 19–23), startups in various sectors—including accommodation solutions, AI video production, and digital healthcare—secured investments from venture capital (VC) firms and accelerato…
2026-10-24 13:07:04

Corporation

“Do I Really Need a Styler?”… I Tried This One in the 20,000-won Range [Product Review]

We’re in an era of recession-driven consumption, where we want a lot but our wallets are light. Our reporter personally tests and evaluates “value-for-money alternatives” that let you keep up with tre…
2026-10-24 10:00:03

IT·Science

Rokit Healthcare Plunges 20% Following FDA Warning Letter to U.S. Partner [K-bio Pulse]

Korean small-cap pharma, biotech, and healthcare stocks moved in opposite directions on Oct. 22, as large-cap chipmakers weakened. Rokit Healthcare posted the steepest decline on the KOSDAQ, while in-…
2026-10-24 06:17:02